Intrahepatic Hepatitis B Virus Covalently Closed Circular DNA Can Be a Predictor of Sustained Response to Therapy
- 1 June 2005
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 128 (7) , 1890-1897
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆Gastroenterology, 2004
- Durability of Serologic Response After Lamivudine Treatment of Chronic Hepatitis BHepatology, 2003
- Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantationJournal of Medical Virology, 2002
- Effect of virological response on post‐treatment durability of lamivudine‐induced HBeAg seroconversionJournal of Viral Hepatitis, 2002
- Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase regionHepatology, 2001
- The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis BJournal of Hepatology, 2001
- High-Throughput Quantitative Analysis of Hepatitis B Virus DNA in Serum Using the TaqMan Fluorogenic Detection SystemHepatology, 2000
- Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfaHepatology, 1997
- Reversion of duck hepatitis B virus DNA replication in vivo following cessation of treatment with the nucleoside analogue ganciclovirAntiviral Research, 1995
- Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cellsCell, 1986